Smart Injector System with RFID Dose Tracking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing injectors for parenteral solutions from multi-dose containers or large cartridges lack automatic dose restriction and microbiological usage monitoring, leading to potential overdose and prolonged use beyond safe periods, with manual documentation being error-prone and resource-intensive.

Innovation Solution

An injector system that connects to multi-dose containers or large cartridges, utilizing a data storage device (such as RFID) to track and enforce maximum individual doses and usage periods, with a processor controlling the delivery and providing warnings, and enables wireless or cable data transfer for automated documentation and integration with medical systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If manual documentation of product and injection parameters is used, then resource consumption is reduced, but documentation accuracy and reliability deteriorate due to human error

Engineering Contradiction:
Improvedocumentation efficiencyVSAvoiddocumentation accuracy
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent replaces manual documentation (mechanical human operation) with an automated electronic data capture system using RFID technology. The reader automatically reads container identifiers and injection parameters, storing them electronically without human intervention, thereby eliminating human error while improving efficiency

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system enables self-service automation where the RFID reader automatically captures and stores documentation data without requiring manual input from healthcare providers. The system serves itself by automatically tracking usage and generating alerts, reducing both resource consumption and error rates

Inventive Principle:
Principle #25Self-service

2Adaptability or versatility

If maximum filling volume restriction is not implemented in multi-dose containers, then flexibility and adaptability improve, but patient safety deteriorates due to risk of excessive dosing

Engineering Contradiction:
Improvecontainer usage flexibilityVSAvoidoverdose risk
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The system implements feedback control by automatically tracking the volume of solution removed from multi-dose containers and comparing it against maximum safe dosage limits stored in the database. When the limit is approached, the system provides alerts to prevent excessive dosing, maintaining patient safety while allowing flexible container usage

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system performs preliminary action by pre-storing maximum dosage limits and usage parameters in the database before actual injection occurs. This allows the system to proactively monitor and control dosing throughout the container usage period, preventing overdose before it happens

Inventive Principle:
Principle #10Preliminary action

3Device complexity

If usage duration monitoring is not implemented, then device complexity is reduced, but microbiological safety deteriorates due to prolonged container use

Engineering Contradiction:
Improvemonitoring system complexityVSAvoidmicrobiological contamination risk
Core Design Contradiction:
Device complexityVSObject-affected harmful factors

Solution Approach 1:

The system implements feedback control by continuously monitoring the duration of container usage and comparing it against manufacturer-specified time limits stored in the database. When the maximum usage duration is reached, the system automatically alerts users to stop using the container, preventing microbiological contamination while maintaining simple operation

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent replaces complex manual tracking of usage duration with automated electronic monitoring through RFID technology. The system automatically captures opening time, calculates elapsed time, and provides alerts, simplifying the interface while ensuring microbiological safety

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Ensures accurate and safe administration of parenteral solutions by preventing excessive dosing and prolonged use, while automating documentation and enhancing data management for improved safety and efficiency.

Implementation Method 1

The container data storage device may be a radiofrequency identification (RFID) chip

Methodology Applied
Scientific EffectRadiofrequency identification (RFID): Electromagnetic Induction

Data Source

PatentUS9162026B2Injector system
Publication Date: 2015.10.20 BAYER INTPROP GMBH
  • US9162026B2 patent drawing
  • US9162026B2 patent drawing
  • US9162026B2 patent drawing

AI summary

The present disclosure relates to a pump injector containing a processor, a pump or a motor with advance for a piston which is suitable for driving liquid out of a container or a cartridge, a data storage device, and a device for data transfer, wherein the processor is electronically connected to the data storage device, to a control unit for the pump or motor, and to the device for data transfer. The injector is suitable for being connected to a container or a cartridge for fluid transfer, which contains a multiplicity of doses of a parenteral solution and has an additional data storage device fixedly connected thereto. The device for data transfer is suitable for reading out information from the additional data storage device on the container including at least one specification in respect to the identity of the product stored in the container or in the cartridge is stored in the container, a maximum dose per patient, and a maximum usage period after opening the container.